Data for Effects of rosiglitazone treatment on lipid composition (Study ST000675)

(Analysis AN001036)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2
CL 78:3; [M-2H](2-)@7.45 0.8428 1.1572
FFA(16:0) 0.9418 1.0582
FFA(18:0) 0.9720 1.0280
FFA(18:1) 0.8081 1.1919
FFA(18:2) 0.7967 1.2033
FFA(20:0) 0.9192 1.0808
FFA(20:1) 0.6858 1.3142
FFA(20:2) 0.7022 1.2978
FFA(20:4) Arachidonic acid 1.0887 0.9113
FFA(22:0) 0.9367 1.0633
FFA(22:1) 0.8371 1.1629
FFA(22:2) 0.7153 1.2847
FFA(22:3) 0.6710 1.3290
FFA(24:0) 0.9217 1.0783
FFA(24:1) 0.8469 1.1531
FFA(24:2) 0.8758 1.1242
FFA(24:3) 0.9394 1.0606
lysoPE 18:0; [M-H]-@2.40 0.7629 1.2371
lysoPE 18:1; [M-H]-@1.78 0.8885 1.1115
lysoPE 18:2; [M-H]-@1.29 0.9538 1.0462
lysoPE 20:4; [M-H]-@1.28 1.0259 0.9741
lysoPE 22:5; [M-H]-@1.49 0.8395 1.1605
PA 34:2; [M-H]-@6.18 1.0578 0.9422
PC 28:0; [M-Ac-H]-@5.15 0.9161 1.0839
PC 30:0; [M-Ac-H]-@5.87 0.8823 1.1177
PC 30:1; [M-Ac-H]-@5.32 0.7459 1.2541
PC 31:0; [M-Ac-H]-@6.14 0.9551 1.0449
PC 32:0; [M-Ac-H]-@6.49 0.9617 1.0383
PC 32:1; [M-Ac-H]-@5.98 0.8257 1.1743
PC 32:2; [M-Ac-H]-@5.48 0.8593 1.1407
PC 33:1; [M-Ac-H]-@6.33 0.9579 1.0421
PC 33:2; [M-Ac-H]-@5.86 0.9724 1.0276
PC 34:1; [M-Ac-H]-@6.58 0.9414 1.0586
PC 34:2; [M-Ac-H]-@6.13 0.8861 1.1139
PC 34:3; [M-Ac-H]-@5.66 0.8062 1.1938
PC 35:1; [M-Ac-H]-@6.91 0.9335 1.0665
PC 35:2; [M-Ac-H]-@6.46 0.8515 1.1485
PC 35:3; [M-Ac-H]-@6.01 0.8233 1.1767
PC 36:1; [M-Ac-H]-@7.19 0.9797 1.0203
PC 36:2; [M-Ac-H]-@6.72 0.8817 1.1183
PC 36:3; [M-Ac-H]-@6.29 0.8483 1.1517
PC 36:4; [M-Ac-H]-@6.02 0.9048 1.0952
PC 36:5; [M-Ac-H]-@5.57 0.7287 1.2713
PC 37:4; [M-Ac-H]-@6.42 0.7366 1.2634
PC 38:2; [M-Ac-H]-@7.30 0.7922 1.2078
PC 38:3; [M-Ac-H]-@6.95 0.8378 1.1622
PC 38:4; [M-Ac-H]-@6.68 0.8966 1.1034
PC 38:5; [M-Ac-H]-@6.26 0.8688 1.1312
PC 38:7; [M-Ac-H]-@5.45 0.6360 1.3640
PC 40:4; [M-Ac-H]-@7.19 0.8775 1.1225
PC 40:5; [M-Ac-H]-@6.97 0.7876 1.2124
PC 40:7; [M-Ac-H]-@6.11 0.6254 1.3746
PC 40:8; [M-Ac-H]-@5.70 0.9756 1.0244
PE 30:0; [M-H]-@6.02 0.7861 1.2139
PE 32:2; [M-H]-@5.64 0.7814 1.2186
PE 34:1; [M-H]-@6.76 0.8135 1.1865
PE 34:2; [M-H]-@6.31 0.9071 1.0929
PE 34:3; [M-H]-@5.87 0.7860 1.2140
PE 35:1; [M-H]-@7.07 0.9004 1.0996
PE 35:2; [M-H]-@6.58 0.8876 1.1124
PE 35:4; [M-H]-@5.98 1.0863 0.9137
PE 36:1; [M-H]-@6.79 0.8999 1.1001
PE 36:1; [M-H]-@7.35 0.8291 1.1709
PE 36:2; [M-H]-@5.99 0.7048 1.2952
PE 36:3; [M-H]-@6.48 0.8666 1.1334
PE 36:5; [M-H]-@5.90 0.8240 1.1760
PE 37:4; [M-H]-@6.62 0.8060 1.1940
PE 38:1; [M-H]-@7.84 0.7983 1.2017
PE 38:3; [M-H]-@7.17 1.0128 0.9872
PE 38:4; [M-H]-@6.89 0.9125 1.0875
PE 40:1; [M-H]-@8.32 0.9403 1.0597
PE 40:2; [M-H]-@7.88 0.7302 1.2698
PE 40:5; [M-H]-@6.91 0.8839 1.1161
PE 40:6; [M-H]-@6.85 0.8876 1.1124
PE 40:7; [M-H]-@6.33 0.8615 1.1385
PG 32:1; [M-H]-@5.36 0.7285 1.2715
PG 33:0; [M-H]-@6.15 0.7079 1.2921
PG 34:1; [M-H]-@5.91 0.7848 1.2152
PG 34:2; [M-H]-@5.32 0.6776 1.3224
PG 36:0; [M-H]-@6.97 0.9076 1.0924
PG 36:1; [M-H]-@6.55 0.8067 1.1933
PG 36:2; [M-H]-@6.02 0.7847 1.2153
PG 36:3; [M-H]-@5.39 0.8348 1.1652
PG 38:3; [M-H]-@5.91 0.8590 1.1410
PG 38:4; [M-H]-@5.51 0.7882 1.2118
PG 40:5; [M-H]-@5.75 0.9382 1.0618
PI 32:1; [M-H]-@5.15 0.7475 1.2525
PI 34:1; [M-H]-@5.81 0.8858 1.1142
PI 34:2; [M-H]-@5.32 0.8002 1.1998
PI 36:2; [M-H]-@5.94 0.7619 1.2381
PI 36:3; [M-H]-@5.48 0.8063 1.1937
PI 36:4; [M-H]-@5.36 0.8653 1.1347
PI 38:4; [M-H]-@5.94 0.7861 1.2139
PI 38:5; [M-H]-@5.47 0.7810 1.2190
PI 40:5; [M-H]-@6.02 0.8589 1.1411
plasmenyl-PE 33:1; [M-H]-@6.83 0.8040 1.1960
plasmenyl-PE 34:2; [M-H]-@6.63 0.8381 1.1619
plasmenyl-PE 34:3; [M-H]-@6.24 0.8899 1.1101
plasmenyl-PE 36:2; [M-H]-@6.50 0.8943 1.1057
plasmenyl-PE 36:3; [M-H]-@6.78 0.9041 1.0959
plasmenyl-PE 38:1; [M-H]-@8.10 0.9232 1.0768
plasmenyl-PE 38:2; [M-H]-@7.71 0.8392 1.1608
plasmenyl-PE 40:5; [M-H]-@7.29 0.8789 1.1211
PS 32:1; [M-H]-@5.26 0.9202 1.0798
PS 34:1; [M-H]-@5.88 0.7861 1.2139
PS 34:2; [M-H]-@5.44 0.8380 1.1620
PS 36:1; [M-H]-@6.53 0.8418 1.1582
PS 36:2; [M-H]-@6.02 0.7412 1.2588
PS 36:3; [M-H]-@5.64 0.7429 1.2571
PS 36:4; [M-H]-@5.42 0.8471 1.1529
PS 38:3; [M-H]-@6.29 0.8588 1.1412
PS 38:4; [M-H]-@6.06 0.7667 1.2333
PS 38:5; [M-H]-@5.59 0.7272 1.2728
PS 38:6; [M-H]-@5.33 0.8983 1.1017
PS 40:2; [M-H]-@7.26 0.8120 1.1880
PS 40:4; [M-H]-@6.48 0.8739 1.1261
PS 40:5; [M-H]-@6.15 0.8004 1.1996
PS 40:6; [M-H]-@5.97 0.8325 1.1675
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1TYPE:control
F2TYPE:Rosi
  logo